Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2014-12-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Fluoxetine and/or DHEA
NCT03228732
Precision Mental Health in Diabetes - Subtypes of Mental Health, Trajectories, and Patterns With Glycaemic Control
NCT05548699
Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
NCT05492305
Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups
NCT07212075
Endogenous Opioid Activity and Affective State in Insulin Resistant Women
NCT02069379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Validated Iranian versions of Hospital Anxiety and Depression Scale and General Health Questionnaire (GHQ)-12 were used to assess anxiety, depression and psychological distress.
Possible score range for anxiety and depression is from 0 to 21. Scores of 8 or higher on either section were considered as the presence of anxiety or depression and scores of 7 or less were considered as normal status. In the present study, participants who got scores of 4 or more from GHQ were considered to have psychological distress.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Isfahani adults
GI/GL
GI/GL
GI and GL would be categorized as tertile. due to cross-sectional design of this study, intervention would not be applicable.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GI/GL
GI and GL would be categorized as tertile. due to cross-sectional design of this study, intervention would not be applicable.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Uncompleted questionnaire (more than 30% of questions)
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leila Azadbakht
Department of Community Nutrition, School of Nutrition and Food Science
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peyman Adibi, MD
Role: STUDY_CHAIR
Integrative Functional Gastroenterology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
References
Explore related publications, articles, or registry entries linked to this study.
Haghighatdoost F, Azadbakht L, Keshteli AH, Feinle-Bisset C, Daghaghzadeh H, Afshar H, Feizi A, Esmaillzadeh A, Adibi P. Glycemic index, glycemic load, and common psychological disorders. Am J Clin Nutr. 2016 Jan;103(1):201-9. doi: 10.3945/ajcn.114.105445. Epub 2015 Nov 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1364
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.